about
Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Idiosyncratic adverse drug reactions: current conceptsPharmacogenomics of adverse drug reactionsFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyAbacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responsesAcyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide AntimicrobialsPharmacogenomics of off-target adverse drug reactions.Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations.Genotyping for severe drug hypersensitivity.Antiviral drug allergy.Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.Pharmacogenomics of antimicrobial agents.Impact of three Illumina library construction methods on GC bias and HLA genotype calling.A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study.Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population.Testing for drug hypersensitivity syndromes.Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions.Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico.A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.Clinical association between pharmacogenomics and adverse drug reactions.The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.Recent advances in the understanding of severe cutaneous adverse reactions.HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique.HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance.Digging up the human genome: current progress in deciphering adverse drug reactions.
P2860
Q26787099-4E02BA38-353F-49E3-8647-BD53D6AA755DQ26800980-2584D58A-D769-4E67-BC4C-267E24D68697Q26824391-D8A4B98B-4A5A-4BB7-BB22-9D1096CD083BQ27015820-DBB55974-C0EE-47C9-A8E8-08F3B6BEF036Q27692095-D90D17E1-7D66-4006-AB04-7617C9B107A6Q28083449-74E08A89-2EAB-4B36-B271-4234ADABFC39Q28538078-EDBA6EA9-5788-469E-B441-A0F0A447AD61Q28547607-05B35A85-5133-4686-B0F2-1F580F7C86D0Q28550088-D98ED81C-F465-4142-BE3A-B864566727B4Q30400366-8BB0EE42-A9B9-4B0C-ABDF-CDF6D7399245Q30793085-B3304EB3-CA20-48C5-A9C9-4407194409D4Q33582530-9567A959-D03D-4EC8-A1E0-C2021349995AQ34075812-ADE60E0C-4BCE-4191-A51D-D2B745B79B50Q34557668-F43B5A26-DF29-413F-BA01-55473F27DE80Q34714531-8F37BCA4-E808-4F86-8FA9-AF95EC47B9D6Q34977413-2F852F43-042F-4AD8-B80E-1454B30B7414Q35534620-D60011F2-62DE-4073-BF15-89A84DC46908Q35802412-6D7454EC-E715-4C22-8120-2AC9AFC04513Q35863499-442EA8A0-5877-42BD-8589-29ABC645B187Q36740238-54C96796-F60A-48B6-80A1-FED5C3EA5AEFQ36766056-871C129A-345E-4134-ABDD-48BD76253DE7Q37389754-799C98F5-DC9F-4B52-A933-AEBDE9BB30C9Q37404888-08953CE5-1F78-470B-8904-B0C5B22D9E66Q37506497-CFB439CD-2F5A-4FB8-9BE7-51C04BB312B5Q37590883-CBE5777F-1F63-4BA3-9FFD-CF0CCD4BDD58Q37644604-30ACEDAC-28C9-4099-B326-B2B8BEC82D5DQ38123143-2C39607D-4868-439E-95BC-587C74CE585EQ38222509-622D7A9B-045C-4988-9C4C-5A9CB86A6BDBQ38285818-EC9BFA8F-8E2B-42BD-BE44-C7624ABCE876Q38369889-A1CEF21F-494C-4E2E-8823-1B8A6384B1E0Q38391340-BEE055E7-E3C0-4675-852D-65E6F2DA9862Q38431150-BE2EBC31-6E27-4972-92F7-D9398EB6805BQ38637036-9300C43D-0EC7-4AB2-9B26-FC49396D5E30Q38805641-6096F679-C1FF-4971-9D25-ABD13764AC49Q38821279-887D30AF-300F-48B6-80BF-192870BF8297Q38931289-5C0103C8-4AFC-481D-A986-64A972182E54Q39264808-88CF1AB0-4708-4C8D-99AE-8B0CDBC032DCQ41704639-7B105088-31DE-4104-A52D-05EA6A65E154Q41812461-6FE364BE-BF7C-4837-B7A1-8EB01038E5B9Q41889353-A9E75333-D23F-4752-929C-021572DD8AA4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HLA and pharmacogenetics of drug hypersensitivity.
@en
type
label
HLA and pharmacogenetics of drug hypersensitivity.
@en
prefLabel
HLA and pharmacogenetics of drug hypersensitivity.
@en
P2860
P356
P1433
P1476
HLA and pharmacogenetics of drug hypersensitivity
@en
P2093
Simon Mallal
P2860
P304
P356
10.2217/PGS.12.108
P577
2012-08-01T00:00:00Z